By proceeding, you agree to our Terms of Use and Privacy Policy.
Chief Technology Officer
#mucosalimmunology #inflammationresearch #monoclonalantibodies
#Europe
Sander Van Deventer had a critical role in the development of the first commercial monoclonal antibody (Remicade) the first commercial gene therapy in the Western world (Glybera).